ChristensenE., MøllerJ. E., and FaurbyeA.: Neuropathological investigation of 28 brains from patients with dyskinesia.Acta Psychiatr. Scand.46: 14-23, 1970.
2.
CraneG. E.: Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.Am. J. Psychiatry124: 40-48, 1968.
3.
CraneG. E.: Dyskinesia and neuroleptics.Arch. Gen. Psychiatry19: 700-703, 1968.
4.
CraneG. E.: High doses of trifluoperazine and tardive dyskinesia.Arch. Neurol.22: 176-180, 1970.
5.
CurrenJ. P.: Tardive dyskinesia: Side effect or not?Am. J. Psychiatry130: 406-410, 1973.
6.
DegkwitzR.: Extrapyramidal motor disorders following long-term treatment with neuroleptic drugs in:Psychotropic Drugs and Dysfunction of Basal Ganglia. Eds CraneG. E., and GardnerR.Jr., U.S. Public Health Service Publication No. 1938, pp. 22-25. 1969.
7.
FannW. E., DavisJ. M., and JanowskyD. S.: The prevalence of tardive dyskinesias in mental hospital patients.Dis. Nerv. Syst.33: 182-186, 1972.
8.
FaurbyeA., RascheP., Bender PetersonP., BrandborgG., and PakkenbergH.: Neurological symptoms in pharmacotherapy of psychosis.Acta Psychiatr. Scand.40: 10-27, 1964.
9.
FreedmanD. X.: Neurological syndromes associated with antipsychotic drug use: a special editorial report.Arch. Gen. Psychiatry28: 463-467, 1973.
10.
FreemanT.: Symptomatology, diagnosis and course. In:The Schizophrenic Syndrome, Eds BellakL., and LoebL. pp. 325-327, New York. Grüne and Stratton, 1969.
11.
GreenblattD. L., DominickJ. R., StotskyB. A. and DiMascioA.: Phenothiazine-induced dyskinesia in nursing home patients.J. Am. Geriatr. Soc.16: 27-34, 1968.
12.
KazamatsuriH., ChienC-P., and ColeJ. O.: Therapeutic approaches to tardive dyskinesia.Arch. Gen. Psychiatry27: 491-499, 1972.
13.
KazamatsuriH., ChienC-P., and ColeJ. O.: Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.Am. J. Psychiatry130: 479-483, 1973.
14.
KlawansH. L.Jr.: The pharmacology of tardive dyskinesias.Am. J. Psychiatry130: 82-86, 1973.
15.
KlineN. S.: On the rarity of “irreversible” oral dyskinesias following phenothiazines.Am. J. Psychiatry124: 48-54, 1968.
16.
MettlerF. A., and CrandallA.: Neurologic disorders in psychiatric institutions.}. Nerv. Ment. Dis.128: 148-159, 1969.
17.
PakkenbergH., FogR., and NilakantanB.: The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations.Psychopharmacologia29: 329-336, 1973.